Dudediligence.

Insmed Incorporated

INSMNASDAQ · Pharmaceutical Preparations
Write an idea

Financing

SEC filings to 2026-10-05 · every row opens its filing

Shares on issue

218.3M

on 2026-06-30, from 148.6M on 2024-03-31 10-Q ↗

a raise that quarter, at its price

Newest

No limit

S-3ASR of 2026-05-15. An automatic shelf: the form sets no dollar limit. None sold under it to 2026-10-05. S-3ASR ↗

4 of its filings are not read yet.

Warrants

The 10-Q filed 2026-08-06 is not read yet.

Cash

6 quarters

$1.16B on 2026-06-30 ÷ $194.7M a quarter of operating cash used, the average of four quarters. 10-Q ↗

Raised
DateWhatSharesPriceGrossFiling
2025-06-11Public offering7,812,500$96.00$750.0M424B5 ↗